Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
JATT II Acquisition $60 million SPAC IPO
We advised the sole bookrunning manager in connection with the IPO
Manycore Tech HK$1.2 billion IPO
We advised the underwriters on the IPO and HKEX listing
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Sigenergy Technology HK$4.4 billion Hong Kong IPO
We advised Sigenergy Technology on its IPO and HKEX listing
Epiworld International HK$1.6 billion IPO
We advised Epiworld International on its IPO and HKEX listing
Guardian Metal Resources $68 million U.S. IPO
We advised Guardian Metal on its U.S. IPO
PayPay $879.8 million IPO
The deal is the largest stand-alone U.S. listing by a Japanese company
MiniMed $560 million IPO
The carve-out IPO of Medtronic’s diabetes unit is the second largest medtech IPO ever
Averin Capital Acquisition $250 million IPO
We advised the underwriters on the IPO